2025-03-21 – News – www.healthshots.com


US pharma giant Eli Lilly has ventured into India with an anti-obesity and diabetes drug called Mounjaro. This development comes after the drug’s approval from the Central Drugs Standard Control Organisation (CDSCO). This move seems to be strategically planned to address the ever-growing prevalence of obesity as well as type 2 diabetes in India. The …

Read the full article here.

About Us

Your go-to source for comprehensive research and comparisons of top-quality health supplements. We provide unbiased insights through meticulous analysis, offering accurate, evidence-based information to help you make informed decisions.

References

Awards

© 2024 by Health Supplements Review.